According to the Zhitong Finance App, Yipinhong (300723.SZ) issued an announcement. Guangzhou Yipinhong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for phenbrommalone tablets approved and issued by the State Drug Administration. The benzbrommalone tablets approved this time were registered as a chemical in category 3, which is considered to have passed the consistency evaluation. The drug is indicated for primary hyperuricemia and intermittent periods of gout arthritis.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.